1 insider bought shares over the last 90 days, the latest filed 14 Aug 2026.
This page follows insider dealings at EQR as filed with ASX, a company from the Chemicals sector. 3 insiders have disclosed 4 filings since 18 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases, made by 1 insider. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 senior executive.
With 4 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed 2 purchases and no sales.
The clock since the last published purchase (14 August 2026) now reads 65 days.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate EQR Strong Buy (bullish), based on 2 analysts. Average price target: A$0.54.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2024 · cache
4 of 4 declarations
EQR is a company operating in the chemicals and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations